Lovise O. Maehle
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Risk reducing mastectomy in Norwegian BRCA1/2 carriers.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 24, 2024
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 12, 2024
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS).
Journal: Cancers
Published: January 08, 2024
Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome.
Journal: The Prostate
Published: December 21, 2023
"It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing.
Journal: Hereditary cancer in clinical practice
Published: August 18, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Journal: The Lancet. Oncology
Published: July 02, 2021
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Journal: Nature genetics
Published: January 21, 2021
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Journal: Nature genetics
Published: May 01, 2020
Last Updated: 09/26/2026